IQV vs MEDP

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

IQV

48.1
AI Score
VS
IQV Wins

MEDP

46.2
AI Score

Investment Advisor Scores

IQV

48score
Recommendation
HOLD

MEDP

46score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IQV MEDP Winner
Revenue 4.15B 1.41B IQV
Net Income 274.00M 245.23M IQV
Net Margin 6.6% 17.3% MEDP
Operating Income 514.00M 288.33M IQV
ROE 4.4% 56.5% MEDP
ROA 0.9% 11.9% MEDP
Total Assets 29.68B 2.06B IQV
Cash 1.95B 502.69M IQV
Current Ratio 0.75 0.73 IQV

Relative Price Performance (Last 90 Days)

IQV 1M: +2.4% · 3M: +33.4% MEDP 1M: +5.1% · 3M: +9.4%

Current Technical Phase

IQV

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.8% over 20 days), RSI 63

RSI (14): 63.4 · Price: $276.63

MEDP

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.1% over 20 days), RSI 68

RSI (14): 68.2 · Price: $662.48

Fundamentals Snapshot

Metric IQV MEDP
Market Cap — —
Forward P/E 19.2 34.3
Trailing P/E 33.7 36.5
Revenue (TTM) — —
Revenue Growth 0.1% 0.2%
Gross Margin 0.3% 0.7%
Operating Margin 0.1% 0.2%
EPS 8.05 17.03
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, IQV is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.